Screening for Lysosomal Acid Lipase Deficiency

Study Identifier:
ALX-LAL-502
ClinicalTrials.gov Identifier:
NCT02926872
EudraCT Identifier:
N/A
Sponsor:
Alexion Pharmaceuticals, Inc.
Study Contact Information:
N/A
Other

Study Details

Medical Condition
  • Unmapped
Study Drug
    Date
    Nov 2016 - Jun 2017
    Phase 1
    Phase 2
    Phase 3
    Phase 4
    N/A
    Patient Requirements
    Sex: Female & Male
    Age: 2 - 16 Years
    Requirements Information
    Sex
    Female & Male
    Age
    2 - 16 Years

    Study Details

    Medical Condition
    • Unmapped
    Study Drug
      Date
      Nov 2016 - Jun 2017
      Phase 1
      Phase 2
      Phase 3
      Phase 4
      N/A
      Patient Requirements
      Sex: Female & Male
      Age: 2 - 16 Years years
      Requirements Information

      Protocol Summary

      The primary outcome of this study is the development of a clinical profile of pediatric patients with LAL-D, which will enable the Sponsor to provide more focused guidance to the medical community as to which pediatric patients should be tested for LAL-D.

      Trial Locations

      Location
      Status
      Location
      Children's Healthcare of Atlanta
      Atlanta, Georgia, United States, 30342
      Status
      N/A
      Location
      Texas Children's Hospital, Baylor College of Medicine
      Houston, Texas, United States, 77030
      Status
      N/A